Diagnosis and treatment of primary aldosteronism.
Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA.
Lancet Diabetes Endocrinol. 2021 Dec;9(12):876-892. doi: 10.1016/S2213-8587(21)00210-2.
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.
Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, Mulatero P, Murad MH, Touyz RM, Vaidya A, Williams TA, Yang J, Young WF, Zennaro MC, Brito JP.
J Clin Endocrinol Metab. 2025 Aug 7;110(9):2453-2495. doi: 10.1210/clinem/dgaf284.
Pathogenesis and treatment of primary aldosteronism.
Zennaro MC, Boulkroun S, Fernandes-Rosa FL.
Nat Rev Endocrinol. 2020 Oct;16(10):578-589. doi: 10.1038/s41574-020-0382-4. Epub 2020 Jul 28.
Secondary diabetes mellitus due to primary aldosteronism.
Moustaki M, Paschou SA, Vakali EC, Vryonidou A.
Endocrine. 2023 Jan;79(1):17-30. doi: 10.1007/s12020-022-03168-8. Epub 2022 Aug 24.
"SECONDARY" ALDOSTERONISM.
GWINUP G, HAMWI GJ.
JAMA. 1965 Mar 15;191:951-2. doi: 10.1001/jama.1965.03080110075040.
Secondary aldosteronism.
Corry DB, Tuck ML.
Endocrinol Metab Clin North Am. 1995 Sep;24(3):511-29.
Key to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis.
Zuo R, Liu S, Xu L, Pang H.
Curr Hypertens Rep. 2023 Dec;25(12):471-480. doi: 10.1007/s11906-023-01269-x. Epub 2023 Oct 3.
Diagnosis of primary hyperaldosteronism.
Araujo-Castro M, Parra-Ramírez P.
Med Clin (Barc). 2022 May 13;158(9):424-430. doi: 10.1016/j.medcli.2021.10.012. Epub 2021 Dec 16.
Approach to the Patient: Reninoma.
Hayes AG, Stowasser M, Umapathysivam MM, Falhammar H, Torpy DJ.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e809-e816. doi: 10.1210/clinem/dgad516.
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks.
Mullen N, Curneen J, Donlon PT, Prakash P, Bancos I, Gurnell M, Dennedy MC.
Endocr Rev. 2024 Jan 4;45(1):125-170. doi: 10.1210/endrev/bnad026.
